Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Factors associated with ventricular inducibility in the MADIT-II study population.

Sesselberg HW, Moss AJ, Steinberg J, Carroll E, Zareba W, Daubert J, Huang DT.

Am J Cardiol. 2003 Apr 15;91(8):1002-4, A7. No abstract available.

PMID:
12686349
2.

Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ; MADIT II Study Investigators..

J Am Coll Cardiol. 2006 Jan 3;47(1):98-107.

3.

QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ; Multicenter Automatic Defibrillator Implantation Trial II investigators..

J Am Coll Cardiol. 2004 Oct 6;44(7):1481-7.

4.

Post-infarction ventricular arrhythmias originating in papillary muscles.

Bogun F, Desjardins B, Crawford T, Good E, Jongnarangsin K, Oral H, Chugh A, Pelosi F, Morady F.

J Am Coll Cardiol. 2008 May 6;51(18):1794-802. doi: 10.1016/j.jacc.2008.01.046.

5.

Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ; MADIT-II Investigators..

J Am Coll Cardiol. 2005 Nov 1;46(9):1712-20.

6.
7.

Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.

Gardiwal A, Yu H, Oswald H, Luesebrink U, Ludwig A, Pichlmaier AM, Drexler H, Klein G.

Europace. 2008 Mar;10(3):358-63. doi: 10.1093/europace/eun019.

8.
9.

Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.

Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.

Europace. 2006 Aug;8(8):618-24.

10.

Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.

Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM; TOVA Investigators..

Circulation. 2004 Mar 23;109(11):1386-91.

11.

Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.

Gillis AM, Sheldon RS, Wyse DG, Duff HJ, Cassidy MR, Mitchell LB.

J Cardiovasc Electrophysiol. 2003 May;14(5):492-8.

PMID:
12776866
12.

Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.

Gibson CM, Pride YB, Buros JL, Lord E, Shui A, Murphy SA, Pinto DS, Zimetbaum PJ, Sabatine MS, Cannon CP, Josephson ME; TIMI Study Group..

J Am Coll Cardiol. 2008 Feb 5;51(5):546-51. doi: 10.1016/j.jacc.2007.08.061.

13.

Effect of cardiac resynchronization therapy on inducibility of ventricular tachyarrhythmias in cardiac arrest survivors with either ischemic or idiopathic dilated cardiomyopathy.

Kiès P, Bax JJ, Molhoek SG, Bleeker GB, Zeppenfeld K, Bootsma M, van Erven L, Steendijk P, van der Wall EE, Schalij MJ.

Am J Cardiol. 2005 May 1;95(9):1111-4.

PMID:
15842986
14.

Fatal outcome from inappropriate defibrillation.

Dimitri H, John B, Young GD, Sanders P.

Europace. 2007 Nov;9(11):1059-60.

15.

Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.

Pride YB, Appelbaum E, Lord EE, Sloan S, Cannon CP, Sabatine MS, Gibson CM; TIMI Study Group..

Am J Cardiol. 2009 Aug 15;104(4):475-9. doi: 10.1016/j.amjcard.2009.04.005.

PMID:
19660597
16.
17.

Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).

Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ.

Am J Cardiol. 2008 Dec 1;102(11):1427-32. doi: 10.1016/j.amjcard.2008.07.033.

PMID:
19026290
18.

Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.

Lo R, Mitrache A, Quan W, Cohen TJ.

J Invasive Cardiol. 2007 Jan;19(1):12-5.

PMID:
17297178
19.

Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10-minute holter recording.

Berkowitsch A, Zareba W, Neumann T, Erdogan A, Nitt SM, Moss AJ, Pitschner HF.

Ann Noninvasive Electrocardiol. 2004 Jul;9(3):270-9.

PMID:
15245344
20.

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators..

J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65. doi: 10.1016/j.jacc.2007.09.073.

Items per page

Supplemental Content

Support Center